Vicinium

Sesen Bio reports data update from phase 3 trial for high-risk non-muscle invasive bladder cancer
Pharmaceutical Business Review
Sat, 08/10/19 - 01:54 pm
Sesen Bio
clinical trials
Vicinium
bladder cancer
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
Yahoo/Benzinga
Mon, 12/31/18 - 11:57 am
Goldman Sachs
Portola Pharmaceuticals
AndexXa
Sesen Bio
Vicinium